ai3Bio launches from stealth, Matchpoint's big raise for new autoimmune drug, layoffs at Foghorn and Enanta
Plus another Eli Lilly acquisition moves to Arsenal Yards
Kymera and Psithera's Funding Haul
A Multi-Million dollar public offering, the developing race for a dupilumab alternative, business awards, and more.